News & Announcements
Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio
High-density EEG complements Magstim’s Transcranial Magnetic Stimulation Technology Driving Innovation MINNEAPOLIS, Minn. & Carmarthenshire, UK — (July 2, 2020) – Magstim, the global leader in Transcranial Magnetic Stimulation (TMS), today announced an agreement to acquire the product portfolio [...]
Sirnaomics and Precision NanoSystems Have Formed a Partnership Developing and Manufacturing Novel RNAi Drug Candidates Using Precision NanoSystems’ NxGen™ Platform
Gaithersburg, MD, and Vancouver, Canada – Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the development and manufacture of the polypeptide nanoparticle-based RNAi therapeutic product. This strategic joint effort includes the execution of a NanoA [...]
Agena Bioscience Announces EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel
Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced the launch of the iPLEX® Pro SARS-CoV-2 Panel for qualitative detection of the novel coronavirus that causes COVID-19. Clinical laboratories can process more than 6000 samples each day ru [...]
Specific Diagnostics Announces that NIAID has Awarded the Company a Further $2.9 million for the Commercial Development of the Reveal Rapid Antibiotic Susceptibility Testing (AST) System
MOUNTAIN VIEW, California, June 2, 2020 – Specific Diagnostics today announces that the National Institute for Allergy and Infectious Disease (NIAID) has awarded a second major grant to drive the commercial introduction of Specific’s Reveal system, which provides quantitative determination of antib [...]
CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
- CanSinoBIO will license in Precision NanoSystems’ proprietary RNA vaccine platform technology - Precision NanoSystems will lead RNA vaccine formulation development - CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials Tianjin, China and Vancouver, Canada – CanSin [...]
Nivagen Pharmaceuticals Closes $16 Million Growth Equity Financing from Telegraph Hill Partners
Additional Resources Will Support Product Development and Expansion of Manufacturing Capabilities Sacramento, Calif.—(May 19, 2020)—Nivagen Pharmaceuticals, Inc. (“Nivagen”), a specialty pharmaceuticals company, announced the closing of a $16 million equity financing round led by Telegraph Hill Pa [...]
Nimble announces collaboration to discover and develop novel peptide-based compounds for SARS-CoV-2 diagnostics
MADISON, WI--Nimble Therapeutics, Inc. today announced a collaboration with Roche Diagnostics to accelerate discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro diagnostic assays. Nimble will extend its proprietary peptide synthesis, screening and optimization platfo [...]